Skip to content
M P8M P8M P8

Drawing based on the label description. No photo yet.

“20 mg tablets are dark yellow, film-coated, oval, unscored tablets imprinted with M P8 in black ink on one side of the tablet and blank on the other side. The”

M P8 pill

Pill with imprint M P8 is yellow, oval, 8 mm and has been identified as Pantoprazole Sodium 20 mg. It is used for acid reflux (GERD), heartburn and H. pylori infection. It is supplied by Mylan Pharmaceuticals Inc.

Pantoprazole Sodium 20 mg

Imprint
M P8
Strength
20 mg
Used for
Acid reflux (GERD), heartburn and H. pylori infection
Color
Yellow
Shape
Oval
Size
8 mm
Score
No score line
Form
Tablet, delayed release
Manufacturer
Mylan Pharmaceuticals Inc
Drug class
Acid reducer (proton pump inhibitor)
NDC
0378-6688, 0378-6688-77, 0378-6688-99, 80425-0179, 80425-0179-2, 80425-0179-3

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Pantoprazole Sodium pills and guides

What is Pantoprazole Sodium used for?

Pantoprazole Sodium is used for acid reflux (GERD), heartburn, H. pylori infection and Zollinger-Ellison syndrome.

Medicine type
Acid reducer (proton pump inhibitor)
Official uses from the US prescribing label

Pantoprazole sodium delayed-release tablets are indicated for:

Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD)

Pantoprazole sodium delayed-release tablets are indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis (EE). For those adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole sodium delayed-release tablets may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been established.

Maintenance of Healing of Erosive Esophagitis

Pantoprazole sodium delayed-release tablets are indicated for maintenance of healing of EE and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD. Controlled studies did not extend beyond 12 months.

Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome

Pantoprazole sodium delayed-release tablets are indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison (ZE) Syndrome.

From the FDA-approved label on DailyMed (published Sep 29, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows M P8 and the other side is plain.
  • It is yellow, oval, 8 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Pantoprazole Sodium

Inactive: Ferrosoferric Oxide, Calcium Stearate, Crospovidone (35 .mu.m), Hypromellose, Unspecified, Mannitol, Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Type A, Povidone K90, Povidone K25, Propylene Glycol, Sodium Carbonate, Shellac, Titanium Dioxide, Triethyl Citrate, Ferric Oxide Yellow

Also distributed by

Advanced Rx Pharmacy of Tennessee, LLC

Other pills with imprint M P8

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Pantoprazole Sodium pills